CASP3 and Alzheimer disease: As shown in Figure 5, the number of activated caspase-3 immunolabeled cells as well as the covered areas of activated caspase-3 were both significantly increased in the cortex and the hippocampus of the AD model group compared to the NC group (ANOVA with post hoc Tukey’s test, all p < 0.01).